Table 3. Survival analyses for patients who underwent curative resection.
| No of patients (%) | Disease-free survival (DFS) | Overall survival (OS) | |||||
|---|---|---|---|---|---|---|---|
| Mean DFS (months) | Univariate analysis p | Multivariate analysis adjusted HR(95% CI) | Mean OS (months) | Univariate analysis p | Multivariate analysis adjusted HR(95% CI) | ||
| All | 190(100) | 153.8 | 191.6 | ||||
| Gender | 0.226 | 0.169 | |||||
| Female | 85(45) | 164.8 | 201.4 | ||||
| Male | 105(55) | 138.2 | 183.6 | ||||
| Age | 0.773 | 0.544 | |||||
| <70 | 154(81) | 152 | 192.9 | ||||
| ≥70 | 36(19) | 141 | 156.1 | ||||
| N stage | <0.001 | 2.731(1.525~4.888) | 0.001 | 4.671(1.655~13.185) | |||
| N0 | 114(60) | 174.8 | 204.0 | ||||
| ≥N1 | 76(40) | 121.3 | 171.9 | ||||
| LNR | <0.001 | 3.582(2.048~6.265) | 0.002 | 4.009(1.585~10.141) | |||
| <0.1 | 143(75) | 170.4 | 199.5 | ||||
| ≥0.1 | 47(25) | 99.9 | 165.1 | ||||
| T stage | 0.053 | 0.455 | |||||
| T1,T2 | 35(18) | 177.7 | 195.9 | ||||
| T3,T4 | 155(82) | 146.6 | 190.2 | ||||
| Tumor differentiation | 0.087 | 0.062 | |||||
| Well | 79(42) | 168.7 | 203.3 | ||||
| Mod-poor | 111(58) | 142.1 | 182.5 | ||||
| Romo1 | 0.035 | 2.133(1.167~3.896) | 0.036 | 2.735(1.029~7.271) | |||
| Low | 146(77) | 161 | 196.9 | ||||
| High | 44(23) | 127.6 | 171.3 | ||||
N, lymph node; LNR, lymph node ratio; T, tumor